FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charles O'Brien

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Phenomena

Recurrence

Activities & Behaviors

Co-author Network

Publications

TOP 3
Toni-Kim Clarke; Richard C Crist; Charles Dackis; Thomas N Ferraro; Kyle M Kampman; Falk W Lohoff; Charles P O'Brien; David W Oslin; Helen M Pettinati; Wade H Berrettini
Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.
Reagan R Wetherill; Kimberly A Young; Anna Rose Childress; Kanchana Jagannathan; Charles P O'Brien; Joshua Shin; Teresa R Franklin
The impact of sex on brain responses to smoking cues: a perfusion fMRI study.
R C Crist; Charles Dackis; G A Doyle; T N Ferraro; H Hakonarson; Kyle M Kampman; Falk W Lohoff; Charles P O'Brien; David W Oslin; Helen M Pettinati; M Vaswani; C Yuan; A Zeng; L M Ambrose-Lanci; T K Clarke; W H Berrettini
Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charles O'Brien (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Toni-Kim Clarke; Richard C Crist; Charles Dackis; Thomas N Ferraro; Kyle M Kampman; Falk W Lohoff; Charles P O'Brien; David W Oslin; Helen M Pettinati; Wade H Berrettini
Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.
Neuroscience letters 2013;542():71-5.
2013: Reagan R Wetherill; Kimberly A Young; Anna Rose Childress; Kanchana Jagannathan; Charles P O'Brien; Joshua Shin; Teresa R Franklin
The impact of sex on brain responses to smoking cues: a perfusion fMRI study.
Biology of sex differences 2013;4(1):9.
2013: R C Crist; Charles Dackis; G A Doyle; T N Ferraro; H Hakonarson; Kyle M Kampman; Falk W Lohoff; Charles P O'Brien; David W Oslin; Helen M Pettinati; M Vaswani; C Yuan; A Zeng; L M Ambrose-Lanci; T K Clarke; W H Berrettini
Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations.
Drug and alcohol dependence 2013;127(1-3):122-8.
2012: Charles Dackis; Kyle M Kampman; Kevin G Lynch; Helen M Pettinati; Jennifer G Plebani; Thorne Sparkman; Charles P O'Brien
A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
Journal of substance abuse treatment 2012;43(3):303-12.
2012: Charles P O'Brien
Modafinil-cocaine interactions: clinical implications.
Biological psychiatry 2012;72(5):346.
2012: Teresa R Franklin; Kanchana Jagannathan; Charles P O'Brien; Joshua Shin; Jesse Suh; John A Detre; Anna Rose Childress
Acute baclofen diminishes resting baseline blood flow to limbic structures: a perfusion fMRI study.
Drug and alcohol dependence 2012;125(1-2):60-6.
2012: Charles P O'Brien
Rationale for changes in DSM-5.
Journal of studies on alcohol and drugs 2012;73(4):705.
2012: R Christopher Pierce; Paul J Kenny; Charles P O'Brien; Louk J M J Vanderschuren
Rational development of addiction pharmacotherapies: successes, failures, and prospects.
Cold Spring Harbor perspectives in medicine 2012;2(6):a012880.
2012: Daniel D Langleben; Charles P O'Brien; Elliot L Busch; Igor Elman
Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence.
Psychopharmacology 2012;220(3):559-64.
2012: Jennifer G Plebani; Qin Yu; Kevin G Lynch; Charles P O'Brien; Helen M Pettinati; Kyle M Kampman
Results of an initial clinical trial of varenicline for the treatment of cocaine dependence.
Drug and alcohol dependence 2012;121(1-2):163-6.
2012: Donna M Coviello; Peter D Friedmann; Michael S Gordon; Timothy W Kinlock; Joshua D Lee; Kevin G Lynch; Edward V Nunes; Elie S Nuwayser; Tamara Y Boney; Cynthia A Clark; James W Cornish; Robert P Schwartz; Charles P O'Brien
A multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers.
Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 2012;33(1):48-59.
2011: Teresa Franklin; Ze Wang; Jesse J Suh; Rebecca Hazan; Jeffrey Cruz; Yin Li; Marina Goldman; John A Detre; Charles P O'Brien; Anna Rose Childress
Effects of varenicline on smoking cue–triggered neural and craving responses.
Archives of general psychiatry 2011;68(5):516-26.
2011: Charles P O'Brien; David Gastfriend; Robert F Forman; Edward Schweizer; Helen M Pettinati
Long-term opioid blockade and hedonic response: preliminary data from two open-label extension studies with extended-release naltrexone.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2011;20(2):106-12.
2011: Kyle M Kampman; Charles Dackis; Helen M Pettinati; Kevin G Lynch; Thorne Sparkman; Charles P O'Brien
A double-blind, placebo-controlled pilot trial of acamprosate for the treatment of cocaine dependence.
Addictive behaviors 2011;36(3):217-21.
2011: Martin D Cheatle; Charles P O'Brien
Opioid therapy in patients with chronic noncancer pain: diagnostic and clinical challenges.
Advances in psychosomatic medicine 2011;30():61-91.
2010: David S Metzger; George E Woody; Charles P O'Brien
Drug treatment as HIV prevention: a research update.
Journal of acquired immune deficiency syndromes (1999) 2010;55 Suppl 1():S32-6.
2010: Donna M Coviello; James W Cornish; Kevin G Lynch; Arthur I Alterman; Charles P O'Brien
A randomized trial of oral naltrexone for treating opioid-dependent offenders.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2010;19(5):422-32.
2010: Falk W Lohoff; Paul J Bloch; Rachel Hodge; Aleksandra H Nall; Thomas N Ferraro; Kyle M Kampman; Charles Dackis; Charles P O'Brien; Helen M Pettinati; David W Oslin
Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine dependence.
Neuroscience letters 2010;473(2):87-91.
2010: Marina Goldman; Kevin G Lynch; Charles P O'Brien; Jennifer Ross; Jesse Suh; Regina Szucs; Hu Xie; David W Oslin
Identifying risk factors for marijuana use among veterans affairs patients.
Journal of addiction medicine 2010;4(1):47-51.
2009: Paul J Bloch; Aleksandra H Nall; Andrew E Weller; Thomas N Ferraro; Wade H Berrettini; Kyle M Kampman; Helen M Pettinati; Charles Dackis; Charles P O'Brien; David W Oslin; Falk W Lohoff
Association analysis between polymorphisms in the dopamine D3 receptor (DRD3) gene and cocaine dependence.
Psychiatric genetics 2009;19(5):275-6.
2009: Teresa R Franklin; Derek Harper; Kyle M Kampman; Susan Kildea-McCrea; Will Jens; Kevin G Lynch; Charles P O'Brien; Anna Rose Childress
The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study.
Drug and alcohol dependence 2009;103(1-2):30-6.
2009: Kyle M Kampman; Helen M Pettinati; Kevin G Lynch; Hu Xie; Charles Dackis; David W Oslin; Thorne Sparkman; Tiffany Sharkoski; Charles P O'Brien
Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence.
Addictive behaviors 2009;34(6-7):581-6.
2009: Falk W Lohoff; Paul J Bloch; Thomas N Ferraro; Wade H Berrettini; Helen M Pettinati; Charles Dackis; Charles P O'Brien; Kyle M Kampman; David W Oslin
Association analysis between polymorphisms in the conserved dopamine neurotrophic factor (CDNF) gene and cocaine dependence.
Neuroscience letters 2009;453(3):199-203.
2009: Teresa R Franklin; Falk W Lohoff; Ze Wang; Nathan Sciortino; Derek Harper; Yin Li; Will Jens; Jeffrey Cruz; Kyle M Kampman; Ronald N Ehrman; Wade Berrettini; John A Detre; Charles P O'Brien; Anna Rose Childress
DAT genotype modulates brain and behavioral responses elicited by cigarette cues.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2009;34(3):717-28.
2009: Charles P O'Brien
Neuroplasticity in addictive disorders.
Dialogues in clinical neuroscience 2009;11(3):350-3.
2009: Jesse Suh; Daniel D Langleben; Ronald N Ehrman; Jonathan G Hakun; Ze Wang; Yin Li; Samantha I Busch; Charles P O'Brien; Anna Rose Childress
Low prefrontal perfusion linked to depression symptoms in methadone-maintained opiate-dependent patients.
Drug and alcohol dependence 2009;99(1-3):11-7.
2009: Charles P O'Brien; A Thomas McLellan; Anna Rose Childress; George E Woody
Penn/VA center for studies of addiction.
Neuropharmacology 2009;56 Suppl 1():44-7.
2008: Falk W Lohoff; Andrew E Weller; Paul J Bloch; Aleksandra H Nall; Thomas N Ferraro; Kyle M Kampman; Helen M Pettinati; David W Oslin; Charles Dackis; Charles P O'Brien; Wade H Berrettini
Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(13):3078-84.
2008: Charles P O'Brien
The CAGE questionnaire for detection of alcoholism: a remarkably useful but simple tool.
JAMA : the journal of the American Medical Association 2008;300(17):2054-6.
2008: Jesse Suh; Helen M Pettinati; Kyle M Kampman; Charles P O'Brien
Gender differences in predictors of treatment attrition with high dose naltrexone in cocaine and alcohol dependence.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2008;17(6):463-8.
2008: Charles P O'Brien
Review. Evidence-based treatments of addiction.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 2008;363(1507):3277-86.
2008: Elmer Yu; Karen Miotto; Evaristo Akerele; Ann Montgomery; Ahmed Elkashef; Robert Walsh; Ivan Montoya; Marian W Fischman; Joseph F Collins; Frances McSherry; Kathy Boardman; David K Davies; Charles P O'Brien; Walter Ling; Herbert Kleber; Barbara H Herman
A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal.
Drug and alcohol dependence 2008;97(1-2):158-68.
2008: Falk W Lohoff; Paul J Bloch; Andrew E Weller; Aleksandra H Nall; Glenn A Doyle; Russell J Buono; Thomas N Ferraro; Kyle M Kampman; Helen M Pettinati; Charles Dackis; David W Oslin; Charles P O'Brien; Wade H Berrettini
Genetic variants in the cocaine- and amphetamine-regulated transcript gene (CARTPT) and cocaine dependence.
Neuroscience letters 2008;440(3):280-3.
2008: Charles P O'Brien
[Commentary] modern treatment for prisoners.
Addiction (Abingdon, England) 2008;103(8):1343.
2008: Charles P O'Brien
A 50-year-old woman addicted to heroin: review of treatment of heroin addiction.
JAMA : the journal of the American Medical Association 2008;300(3):314-21.
2008: David W Oslin; Kevin G Lynch; Helen M Pettinati; Kyle M Kampman; Peter Gariti; Lois Gelfand; Thomas Ten Have; Shoshana Wortman; William Dundon; Charles Dackis; Joseph Robert Volpicelli; Charles P O'Brien
A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention.
Alcoholism, clinical and experimental research 2008;32(7):1299-308.
2008: Helen M Pettinati; Kyle M Kampman; Kevin G Lynch; Jesse Suh; Charles Dackis; David W Oslin; Charles P O'Brien
Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence.
Journal of substance abuse treatment 2008;34(4):378-90.
2008: Helen M Pettinati; Kyle M Kampman; Kevin G Lynch; Hu Xie; Charles Dackis; Amanda R Rabinowitz; Charles P O'Brien
A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence.
Addictive behaviors 2008;33(5):651-67.
2008: Teresa R Franklin; Ronald N Ehrman; Kevin G Lynch; Derek Harper; Nathan Sciortino; Charles P O'Brien; Anna Rose Childress
Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis.
Journal of women's health (2002) 2008;17(2):287-92.
2008: Daniel D Langleben; Kosha Ruparel; Igor Elman; Samantha Busch-Winokur; Ramapriyan Pratiwadi; James Loughead; Charles P O'Brien; Anna Rose Childress
Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues.
The American journal of psychiatry 2008;165(3):390-4.
2008: Charles P O'Brien
Prospects for a genomic approach to the treatment of alcoholism.
Archives of general psychiatry 2008;65(2):132-3.
2008: Elmer Yu; Karen Miotto; Evaristo Akerele; Charles P O'Brien; Walter Ling; Herbert Kleber; Marian W Fischman; Ahmed Elkashef; Barbara H Herman; Abeer M Al-Ghananeem
Clinical pharmacokinetics of lofexidine, the alpha 2-adrenergic receptor agonist, in opiate addicts plasma using a highly sensitive liquid chromatography tandem mass spectrometric analysis.
The American journal of drug and alcohol abuse 2008;34(5):611-6.
2008: Anna Rose Childress; Ronald N Ehrman; Ze Wang; Yin Li; Nathan Sciortino; Jonathan Hakun; William Jens; Jesse Suh; John Listerud; Kathleen Marquez; Teresa R Franklin; Daniel D Langleben; John Detre; Charles P O'Brien
Prelude to passion: limbic activation by "unseen" drug and sexual cues.
PloS one 2008;3(1):e1506.
2007: Charles P O'Brien
Toward a rational selection of treatment for addiction.
Current psychiatry reports 2007;9(6):441-2.
2007: Teresa R Franklin; Ze Wang; Jiongjiong Wang; Nathan Sciortino; Derek Harper; Yin Li; Ronald N Ehrman; Kyle M Kampman; Charles P O'Brien; John A Detre; Anna Rose Childress
Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(11):2301-9.
2007: Kyle M Kampman; Helen M Pettinati; Kevin G Lynch; Tom Whittingham; Wayne Macfadden; Charles Dackis; Carlos Tirado; David W Oslin; Thorne Sparkman; Charles P O'Brien
A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism.
Journal of clinical psychopharmacology 2007;27(4):344-51.
2007: donald klein; Charles P O'Brien
Improving detection of adverse effects of marketed drugs.
JAMA : the journal of the American Medical Association 2007;298(3):333-4.
2006: Helen M Pettinati; Charles P O'Brien; Amanda R Rabinowitz; Shoshana P Wortman; David W Oslin; Kyle M Kampman; Charles Dackis
The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
Journal of clinical psychopharmacology 2006;26(6):610-25.
2006: Kyle M Kampman; Charles Dackis; Kevin G Lynch; Helen M Pettinati; Carlos Tirado; Peter Gariti; Thorne Sparkman; Michal Atzram; Charles P O'Brien
A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
Drug and alcohol dependence 2006;85(2):129-37.
2006: Charles P O'Brien; George F Koob; David Mee-Lee; Richard N Rosenthal
New developments in addiction treatment.
The Journal of clinical psychiatry 2006;67(11):1801-12.
2006: Andrew E Weller; John Dahl; Falk W Lohoff; Kyle M Kampman; David W Oslin; Charles Dackis; Thomas N Ferraro; Charles P O'Brien; Wade H Berrettini
No association between polymorphisms in the prostate apoptosis factor-4 gene and cocaine dependence.
Psychiatric genetics 2006;16(5):193-6.
2006: David W Oslin; Wade H Berrettini; Charles P O'Brien
Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone.
Addiction biology 2006;11(3-4):397-403.
2006: Charles P O'Brien; Charles Dackis; Kyle M Kampman
Does modafinil produce euphoria?
The American journal of psychiatry 2006;163(6):1109.
2006: Jesse Suh; Helen M Pettinati; Kyle M Kampman; Charles P O'Brien
The status of disulfiram: a half of a century later.
Journal of clinical psychopharmacology 2006;26(3):290-302.
2006: John Dahl; Joseph F Cubells; Riju Ray; Andrew E Weller; Falk W Lohoff; Thomas N Ferraro; David W Oslin; Kyle M Kampman; Charles Dackis; Yilang Tang; Joel Gelernter; Henry R Kranzler; Charles P O'Brien; Wade H Berrettini
Analysis of variations in the tryptophan hydroxylase-2 (TPH2) gene in cocaine dependence.
Addiction biology 2006;11(1):76-83.
2006: Sandra D Comer; Maria A Sullivan; Elmer Yu; Jami L Rothenberg; Herbert D Kleber; Kyle M Kampman; Charles Dackis; Charles P O'Brien
Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.
Archives of general psychiatry 2006;63(2):210-8.
2005: Riju Ray; Glenn A Doyle; James J Crowley; Russell J Buono; David W Oslin; Ashwin A Patkar; Paolo Mannelli; Peter A DeMaria; Charles P O'Brien; Wade H Berrettini
A functional prodynorphin promoter polymorphism and opioid dependence.
Psychiatric genetics 2005;15(4):295-8.
2005: John Dahl; Kyle M Kampman; David W Oslin; Andrew E Weller; Falk W Lohoff; Thomas N Ferraro; Charles P O'Brien; Wade H Berrettini
Association of a polymorphism in the Homer1 gene with cocaine dependence in an African American population.
Psychiatric genetics 2005;15(4):277-83.
2005: John Dahl; Andrew E Weller; Kyle M Kampman; David W Oslin; Falk W Lohoff; Thomas N Ferraro; Charles P O'Brien; Wade H Berrettini
Confirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependence.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2005;139B(1):106-8.
2005: Charles P O'Brien
Addiction and the medical profession.
Current psychiatry reports 2005;7(5):321.
2005: Charles P O'Brien
Adolescent opioid abuse.
Archives of general psychiatry 2005;62(10):1165.
2005: Charles P O'Brien
Anticraving medications for relapse prevention: a possible new class of psychoactive medications.
The American journal of psychiatry 2005;162(8):1423-31.
2005: Charles Dackis; Charles P O'Brien
Clinical implications of cocaine-induced cortical depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(5):1033; author reply 1034-5.
2005: Rachel J Smith; Glenn A Doyle; Angela M Han; James J Crowley; David W Oslin; Ashwin A Patkar; Paolo Mannelli; Peter A DeMaria; Charles P O'Brien; Wade H Berrettini
Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2005;133B(1):105-9.
2005: Charles P O'Brien
Benzodiazepine use, abuse, and dependence.
The Journal of clinical psychiatry 2005;66 Suppl 2():28-33.
2005: Charles Dackis; Kyle M Kampman; Kevin G Lynch; Helen M Pettinati; Charles P O'Brien
A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2005;30(1):205-11.
2004: Robert M Weinrieb; Charles P O'Brien
A case report of naltrexone for alcoholism in a liver transplant recipient: side effects and safety.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2004;13(5):495-7.
2004: Kyle M Kampman; Helen M Pettinati; Kevin G Lynch; Charles Dackis; Thorne Sparkman; Catherine Weigley; Charles P O'Brien
A pilot trial of topiramate for the treatment of cocaine dependence.
Drug and alcohol dependence 2004;75(3):233-40.
2004: Teresa R Franklin; Kimberly Napier; Ronald N Ehrman; Peter Gariti; Charles P O'Brien; Anna Rose Childress
Retrospective study: influence of menstrual cycle on cue-induced cigarette craving.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 2004;6(1):171-5.
2004: Kyle M Kampman; Helen M Pettinati; Joseph Robert Volpicelli; David M Oslin; Craig Lipkin; Thorne Sparkman; Charles P O'Brien
Cocaine dependence severity predicts outcome in outpatient detoxification from cocaine and alcohol.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2004;13(1):74-82.
2003: James J Crowley; David W Oslin; Ashwin A Patkar; Edward Gottheil; Peter A DeMaria; Charles P O'Brien; Wade H Berrettini; Dorothy E Grice
A genetic association study of the mu opioid receptor and severe opioid dependence.
Psychiatric genetics 2003;13(3):169-73.
2003: David W Oslin; Wade H Berrettini; Henry R Kranzler; Helen M Pettinati; Joel Gelernter; Joseph Robert Volpicelli; Charles P O'Brien
A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2003;28(8):1546-52.
2003: Kyle M Kampman; Helen M Pettinati; Kevin G Lynch; Thorne Sparkman; Charles P O'Brien
A pilot trial of olanzapine for the treatment of cocaine dependence.
Drug and alcohol dependence 2003;70(3):265-73.
2003: Charles P O'Brien; Kevin G Lynch
Can we design and replicate clinical trials with a multiple drug focus.
Drug and alcohol dependence 2003;70(2):135-7.
2003: Charles Dackis; Kevin G Lynch; Elmer Yu; Frederick F Samaha; Kyle M Kampman; James W Cornish; Amy Rowan; Sabrina Poole; Lenae White; Charles P O'Brien
Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study.
Drug and alcohol dependence 2003;70(1):29-37.
2003: Charles P O'Brien
Research advances in the understanding and treatment of addiction.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2003;12 Suppl 2():S36-47.
2002: Michael F Stromberg; Till Sengpiel; Scott A Mackler; Joseph Robert Volpicelli; Charles P O'Brien; Wolfgang H Vogel
Effect of naltrexone on oral consumption of concurrently available ethanol and cocaine in the rat.
Alcohol (Fayetteville, N.Y.) 2002;28(3):169-79.
2002: Ronald N Ehrman; Steven J Robbins; Melissa A Bromwell; Megan E Lankford; John Monterosso; Charles P O'Brien
Comparing attentional bias to smoking cues in current smokers, former smokers, and non-smokers using a dot-probe task.
Drug and alcohol dependence 2002;67(2):185-91.
2002: James W Cornish; Barbara H Herman; Ronald N Ehrman; Steven J Robbins; Anna Rose Childress; Valerani Bead; Catherine A Esmonde; Karen Martz; Sabrina Poole; Frank S Caruso; Charles P O'Brien
A randomized, double-blind, placebo-controlled safety study of high-dose dextromethorphan in methadone-maintained male inpatients.
Drug and alcohol dependence 2002;67(2):177-83.
2002: Michael F Stromberg; Margaret Rukstalis; Scott A Mackler; Joseph Robert Volpicelli; Charles P O'Brien
A comparison of the effects of 6-beta naltrexol and naltrexone on the consumption of ethanol or sucrose using a limited-access procedure in rats.
Pharmacology, biochemistry, and behavior 2002;72(1-2):483-90.
2002: Daniel D Langleben; Lee Schroeder; Joseph A Maldjian; Ruben C Gur; S McDonald; J Daniel Ragland; Charles P O'Brien; Anna Rose Childress
Brain activity during simulated deception: an event-related functional magnetic resonance study.
NeuroImage 2002;15(3):727-32.
2002: Kyle M Kampman; Joseph Robert Volpicelli; Frank D Mulvaney; Margaret Rukstalis; Arthur I Alterman; Helen M Pettinati; Robert M Weinrieb; Charles P O'Brien
Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence.
Addictive behaviors 2002;27(2):251-60.
2002: Teresa R Franklin; Paul D Acton; Joseph A Maldjian; Jason D Gray; Jason R Croft; Charles Dackis; Charles P O'Brien; Anna Rose Childress
Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients.
Biological psychiatry 2002;51(2):134-42.
2002: Charles P O'Brien
Cynthia'a dilemma.
The American journal of bioethics : AJOB 2002;2(2):54-5.
2002: Kyle M Kampman; Helen M Pettinati; Joseph Robert Volpicelli; Gail Kaempf; Ellen Turk; Ambrose Insua; Craig Lipkin; Thorne Sparkman; Charles P O'Brien
Concurrent cocaine withdrawal alters alcohol withdrawal symptoms.
Journal of addictive diseases 2002;21(4):13-26.
2002: Peter Gariti; Arthur I Alterman; Ronald N Ehrman; Frank D Mulvaney; Charles P O'Brien
Detecting smoking following smoking cessation treatment.
Drug and alcohol dependence 2002;65(2):191-6.
2001: John Monterosso; Ronald N Ehrman; K L Napier; Charles P O'Brien; Anna Rose Childress
Three decision-making tasks in cocaine-dependent patients: do they measure the same construct?
Addiction (Abingdon, England) 2001;96(12):1825-37.
2001: Charles Dackis; Charles P O'Brien
Cocaine dependence: a disease of the brain's reward centers.
Journal of substance abuse treatment 2001;21(3):111-7.
2001: Kyle M Kampman; Arthur I Alterman; Joseph Robert Volpicelli; I Maany; E S Muller; D D Luce; E M Mulholland; Abbas F Jawad; G A Parikh; Frank D Mulvaney; Robert M Weinrieb; Charles P O'Brien
Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment.
Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors 2001;15(1):52-9.
2001: Robert M Weinrieb; DH Van Horn; A Thomas McLellan; Arthur I Alterman; Joseph S Calarco; Charles P O'Brien; Michael R Lucey
Alcoholism treatment after liver transplantation: lessons learned from a clinical trial that failed.
Psychosomatics 2001;42(2):110-6.
2001: Michael F Stromberg; Scott A Mackler; Joseph Robert Volpicelli; Charles P O'Brien
Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption.
Alcohol (Fayetteville, N.Y.) 2001;23(2):109-16.
2001: Michael F Stromberg; Scott A Mackler; Joseph Robert Volpicelli; Charles P O'Brien; S L Dewey
The effect of gamma-vinyl-GABA on the consumption of concurrently available oral cocaine and ethanol in the rat.
Pharmacology, biochemistry, and behavior 2001;68(2):291-9.
2001: John Monterosso; Barbara A Flannery; Helen M Pettinati; David W Oslin; Margaret Rukstalis; Charles P O'Brien; Joseph Robert Volpicelli
Predicting treatment response to naltrexone: the influence of craving and family history.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2001;10(3):258-68.
2001: James W Cornish; I Maany; Paul J Fudala; Ronald N Ehrman; Steven J Robbins; Charles P O'Brien
A randomized, double-blind, placebo-controlled study of ritanserin pharmacotherapy for cocaine dependence.
Drug and alcohol dependence 2001;61(2):183-9.
2000: Kyle M Kampman; Joseph Robert Volpicelli; Arthur I Alterman; James Cornish; Charles P O'Brien
Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms.
The American journal of psychiatry 2000;157(12):2052-4.
2000: Margaret Rukstalis; Michael F Stromberg; Charles P O'Brien; Joseph Robert Volpicelli
6-beta-naltrexol reduces alcohol consumption in rats.
Alcoholism, clinical and experimental research 2000;24(10):1593-6.
2000: Kyle M Kampman; Margaret Rukstalis; Helen M Pettinati; E Muller; T Acosta; Peter Gariti; Ronald N Ehrman; Charles P O'Brien
The combination of phentermine and fenfluramine reduced cocaine withdrawal symptoms in an open trial.
Journal of substance abuse treatment 2000;19(1):77-9.
2000: James R McKay; Arthur I Alterman; John S Cacciola; Frank D Mulvaney; Charles P O'Brien
Prognostic significance of antisocial personality disorder in cocaine-dependent patients entering continuing care.
The Journal of nervous and mental disease 2000;188(5):287-96.
2000: Steven J Robbins; Ronald N Ehrman; Anna Rose Childress; James W Cornish; Charles P O'Brien
Mood state and recent cocaine use are not associated with levels of cocaine cue reactivity.
Drug and alcohol dependence 2000;59(1):33-42.
2000: Helen M Pettinati; Margaret Rukstalis; GJ Luck; Joseph Robert Volpicelli; Charles P O'Brien
Gender and psychiatric comorbidity: impact on clinical presentation of alcohol dependence.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2000;9(3):242-52.
2000: Helen M Pettinati; Joseph Robert Volpicelli; JD Pierce; Charles P O'Brien
Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients.
Journal of addictive diseases 2000;19(1):71-83.
2000: Anna Rose Childress; Charles P O'Brien
Dopamine receptor partial agonists could address the duality of cocaine craving.
Trends in pharmacological sciences 2000;21(1):6-9.
2000: Joseph Robert Volpicelli; I Markman; John Monterosso; J Filing; Charles P O'Brien
Psychosocially enhanced treatment for cocaine-dependent mothers: evidence of efficacy.
Journal of substance abuse treatment 2000;18(1):41-9.
1999: Myroslava K Romach; P Glue; Kyle M Kampman; Howard L Kaplan; Gail R Somer; Sabrina Poole; L Clarke; V Coffin; James Cornish; Charles P O'Brien; Edward M Sellers
Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)
Archives of general psychiatry 1999;56(12):1101-6.
1999: Michael F Stromberg; Joseph Robert Volpicelli; Charles P O'Brien; Scott A Mackler
The NMDA receptor partial agonist, 1-aminocyclopropanecarboxylic acid (ACPC), reduces ethanol consumption in the rat.
Pharmacology, biochemistry, and behavior 1999;64(3):585-90.
1999: James R McKay; Arthur I Alterman; John S Cacciola; Charles P O'Brien; Janelle Koppenhaver; Donald S Shepard
Continuing care for cocaine dependence: comprehensive 2-year outcomes.
Journal of consulting and clinical psychology 1999;67(3):420-7.
1999: Kyle M Kampman; Margaret Rukstalis; Ronald N Ehrman; D E McGinnis; Peter Gariti; Joseph Robert Volpicelli; Helen M Pettinati; Charles P O'Brien
Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence.
Addictive behaviors 1999;24(2):287-91.
1999: David W Oslin; Helen M Pettinati; Joseph Robert Volpicelli; A L Wolf; Kyle M Kampman; Charles P O'Brien
The effects of naltrexone on alcohol and cocaine use in dually addicted patients.
Journal of substance abuse treatment 1999;16(2):163-7.
1999: Steven J Robbins; Ronald N Ehrman; Anna Rose Childress; Charles P O'Brien
Comparing levels of cocaine cue reactivity in male and female outpatients.
Drug and alcohol dependence 1999;53(3):223-30.
1999: David W Oslin; Charles P O'Brien; I R Katz
The disabling nature of comorbid depression among older DUI recipients.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 1999;8(2):128-35.
1999: Anna Rose Childress; P David Mozley; WT McElgin; J Fitzgerald; Martin Reivich; Charles P O'Brien
Limbic activation during cue-induced cocaine craving.
The American journal of psychiatry 1999;156(1):11-8.
1998: Michael F Stromberg; Joseph Robert Volpicelli; Charles P O'Brien
Effects of naltrexone administered repeatedly across 30 or 60 days on ethanol consumption using a limited access procedure in the rat.
Alcoholism, clinical and experimental research 1998;22(9):2186-91.
1998: David W Oslin; Helen M Pettinati; GJ Luck; A Semwanga; Avital Cnaan; Charles P O'Brien
Clinical correlations with carbohydrate-deficient transferrin levels in women with alcoholism.
Alcoholism, clinical and experimental research 1998;22(9):1981-5.
1998: Ronald N Ehrman; Steven J Robbins; Anna Rose Childress; L Goehl; A V Hole; Charles P O'Brien
Laboratory exposure to cocaine cues does not increase cocaine use by outpatient subjects.
Journal of substance abuse treatment 1998;15(5):431-5.
1998: James R McKay; Arthur I Alterman; A Thomas McLellan; Chris Boardman; Frank D Mulvaney; Charles P O'Brien
Random versus nonrandom assignment in the evaluation of treatment for cocaine abusers.
Journal of consulting and clinical psychology 1998;66(4):697-701.
1998: Michael F Stromberg; M Casale; L Volpicelli; Joseph Robert Volpicelli; Charles P O'Brien
A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat.
Alcohol (Fayetteville, N.Y.) 1998;15(4):281-9.
1998: James R McKay; A Thomas McLellan; Arthur I Alterman; John S Cacciola; Megan J Rutherford; Charles P O'Brien
Predictors of participation in aftercare sessions and self-help groups following completion of intensive outpatient treatment for substance abuse.
Journal of studies on alcohol 1998;59(2):152-62.
1998: Charles P O'Brien; Anna Rose Childress; Ronald N Ehrman; Steven J Robbins
Conditioning factors in drug abuse: can they explain compulsion?
Journal of psychopharmacology (Oxford, England) 1998;12(1):15-22.
1997: Helen M Pettinati; JD Pierce; A L Wolf; Margaret Rukstalis; Charles P O'Brien
Gender differences in comorbidly depressed alcohol-dependent outpatients.
Alcoholism, clinical and experimental research 1997;21(9):1742-6.
1997: James W Cornish; D Metzger; George E Woody; D Wilson; A Thomas McLellan; B Vandergrift; Charles P O'Brien
Naltrexone pharmacotherapy for opioid dependent federal probationers.
Journal of substance abuse treatment 1997;14(6):529-34.
1997: Charles P O'Brien
A range of research-based pharmacotherapies for addiction.
Science (New York, N.Y.) 1997;278(5335):66-70.
1997: James R McKay; Arthur I Alterman; John S Cacciola; Megan J Rutherford; Charles P O'Brien; Janelle Koppenhaver
Group counseling versus individualized relapse prevention aftercare following intensive outpatient treatment for cocaine dependence: initial results.
Journal of consulting and clinical psychology 1997;65(5):778-88.
1997: Joseph Robert Volpicelli; K C Rhines; J S Rhines; L A Volpicelli; Arthur I Alterman; Charles P O'Brien
Naltrexone and alcohol dependence. Role of subject compliance.
Archives of general psychiatry 1997;54(8):737-42.
1997: A Thomas McLellan; G R Grissom; David A Zanis; Mary Randall; P Brill; Charles P O'Brien
Problem-service 'matching' in addiction treatment. A prospective study in 4 programs.
Archives of general psychiatry 1997;54(8):730-5.
1997: Charles P O'Brien; A Thomas McLellan
Addiction medicine.
JAMA : the journal of the American Medical Association 1997;277(23):1840-1.
1997: Robert M Weinrieb; Charles P O'Brien
Current research in the treatment of alcoholism in liver transplant recipients.
Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 1997;3(3):328-36.
1997: Steven J Robbins; Ronald N Ehrman; Anna Rose Childress; Charles P O'Brien
Relationships among physiological and self-report responses produced by cocaine-related cues.
Addictive behaviors 1997;22(2):157-67.
1997: A C King; Joseph Robert Volpicelli; Alan Frazer; Charles P O'Brien
Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence.
Psychopharmacology 1997;129(1):15-22.
1997: Robert M Weinrieb; Charles P O'Brien
Naltrexone in the treatment of alcoholism.
Annual review of medicine 1997;48():477-87.
1996: Ronald N Ehrman; Steven J Robbins; James W Cornish; Anna Rose Childress; Charles P O'Brien
Failure of ritanserin to block cocaine cue reactivity in humans.
Drug and alcohol dependence 1996;42(3):167-74.
1996: Charles P O'Brien
Recent developments in the pharmacotherapy of substance abuse.
Journal of consulting and clinical psychology 1996;64(4):677-86.
1996: Kyle M Kampman; Joseph Robert Volpicelli; Arthur I Alterman; J Cornish; Robert M Weinrieb; L Epperson; T Sparkman; Charles P O'Brien
Amantadine in the early treatment of cocaine dependence: a double-blind, placebo-controlled trial.
Drug and alcohol dependence 1996;41(1):25-33.
1996: Charles P O'Brien
Presentation of 1995 J. Michael Morrison Award.
NIDA research monograph 1996;162():20.
1996: Charles P O'Brien; L A Volpicelli; Joseph Robert Volpicelli
Naltrexone in the treatment of alcoholism: a clinical review.
Alcohol (Fayetteville, N.Y.) 1996;13(1):35-9.
1996: James W Cornish; Charles P O'Brien
Crack cocaine abuse: an epidemic with many public health consequences.
Annual review of public health 1996;17():259-73.
1995: Joseph Robert Volpicelli; L A Volpicelli; Charles P O'Brien
Medical management of alcohol dependence: clinical use and limitations of naltrexone treatment.
Alcohol and alcoholism (Oxford, Oxfordshire) 1995;30(6):789-98.
1995: A Droungas; Ronald N Ehrman; Anna Rose Childress; Charles P O'Brien
Effect of smoking cues and cigarette availability on craving and smoking behavior.
Addictive behaviors 1995;20(5):657-73.
1995: George E Woody; A Thomas McLellan; Lester Luborsky; Charles P O'Brien
Psychotherapy in community methadone programs: a validation study.
The American journal of psychiatry 1995;152(9):1302-8.
1995: James W Cornish; I Maany; Paul J Fudala; S Neal; Sabrina Poole; P Volpicelli; Charles P O'Brien
Carbamazepine treatment for cocaine dependence.
Drug and alcohol dependence 1995;38(3):221-7.
1995: Peter Gariti; Arthur I Alterman; E Holub-Beyer; Joseph Robert Volpicelli; N Prentice; Charles P O'Brien
Effects of an appointment reminder call on patient show rates.
Journal of substance abuse treatment 1995;12(3):207-12.
1995: Joseph Robert Volpicelli; N T Watson; A C King; C E Sherman; Charles P O'Brien
Effect of naltrexone on alcohol "high" in alcoholics.
The American journal of psychiatry 1995;152(4):613-5.
1995: James R McKay; Arthur I Alterman; A Thomas McLellan; E C Snider; Charles P O'Brien
Effect of random versus nonrandom assignment in a comparison of inpatient and day hospital rehabilitation for male alcoholics.
Journal of consulting and clinical psychology 1995;63(1):70-8.
1995: Charles P O'Brien; G E Woody; A T McLellan
Enhancing the effectiveness of methadone using psychotherapeutic interventions.
NIDA research monograph 1995;150():5-18.
1995: F W Frey; Elias Abrutyn; D S Metzger; George E Woody; Charles P O'Brien; P Trusiani
Focal networks and HIV risk among African-American male intravenous drug users.
NIDA research monograph 1995;151():89-108.
1995: Joseph Robert Volpicelli; K L Clay; N T Watson; Charles P O'Brien
Naltrexone in the treatment of alcoholism: predicting response to naltrexone.
The Journal of clinical psychiatry 1995;56 Suppl 7():39-44.
1994: A Thomas McLellan; Arthur I Alterman; D S Metzger; G R Grissom; George E Woody; L Luborsky; Charles P O'Brien
Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: role of treatment services.
Journal of consulting and clinical psychology 1994;62(6):1141-58.
1994: Charles P O'Brien
Treatment of alcoholism as a chronic disorder.
Alcohol (Fayetteville, N.Y.) 1994;11(6):433-7.
1994: Charles P O'Brien
Overview: the treatment of drug dependence.
Addiction (Abingdon, England) 1994;89(11):1565-9.
1994: I O Arndt; A Thomas McLellan; L Dorozynsky; George E Woody; Charles P O'Brien
Desipramine treatment for cocaine dependence. Role of antisocial personality disorder.
The Journal of nervous and mental disease 1994;182(3):151-6.
1994: Charles P O'Brien
Treatment of alcoholism as a chronic disorder.
EXS 1994;71():349-59.
1993: D S Metzger; George E Woody; A Thomas McLellan; Charles P O'Brien; P Druley; Helen Navaline; D DePhilippis; PD Stolley; Elias Abrutyn
Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up.
Journal of acquired immune deficiency syndromes 1993;6(9):1049-56.
1993: Robert M Weinrieb; Charles P O'Brien
Persistent cognitive deficits attributed to substance abuse.
Neurologic clinics 1993;11(3):663-91.
1993: A Thomas McLellan; G R Grissom; P Brill; J Durell; D S Metzger; Charles P O'Brien
Private substance abuse treatments: are some programs more effective than others?
Journal of substance abuse treatment 1993;10(3):243-54.
1993: A Thomas McLellan; I O Arndt; D S Metzger; George E Woody; Charles P O'Brien
The effects of psychosocial services in substance abuse treatment.
JAMA : the journal of the American Medical Association 1993;269(15):1953-9.
1993: Anna Rose Childress; A V Hole; Ronald N Ehrman; Steven J Robbins; A Thomas McLellan; Charles P O'Brien
Cue reactivity and cue reactivity interventions in drug dependence.
NIDA research monograph 1993;137():73-95.
1993: Charles P O'Brien; Anna Rose Childress; A Thomas McLellan; Ronald N Ehrman
Developing treatments that address classical conditioning.
NIDA research monograph 1993;135():71-91.
1993: Arthur I Alterman; Charles P O'Brien; M Droba
Day hospital vs. inpatient rehabilitation of cocaine abusers: an interim report.
NIDA research monograph 1993;135():150-62.
1992: I O Arndt; L Dorozynsky; George E Woody; A Thomas McLellan; Charles P O'Brien
Desipramine treatment of cocaine dependence in methadone-maintained patients.
Archives of general psychiatry 1992;49(11):888-93.
1992: Joseph Robert Volpicelli; Arthur I Alterman; M Hayashida; Charles P O'Brien
Naltrexone in the treatment of alcohol dependence.
Archives of general psychiatry 1992;49(11):876-80.
1992: Steven J Robbins; Ronald N Ehrman; Anna Rose Childress; Charles P O'Brien
Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride.
Addictive behaviors 1992;17(5):491-9.
1992: Charles P O'Brien; Anna Rose Childress; A Thomas McLellan; Ronald N Ehrman
Classical conditioning in drug-dependent humans.
Annals of the New York Academy of Sciences 1992;654():400-15.
1992: A Thomas McLellan; Arthur I Alterman; John S Cacciola; D Metzger; Charles P O'Brien
A new measure of substance abuse treatment. Initial studies of the treatment services review.
The Journal of nervous and mental disease 1992;180(2):101-10.
1992: Charles P O'Brien; A Thomas McLellan; A Alterman; Anna Rose Childress
Psychotherapy for cocaine dependence.
Ciba Foundation symposium 1992;166():207-16; discussion 216-23.
1992: Ronald N Ehrman; Steven J Robbins; Anna Rose Childress; Charles P O'Brien
Conditioned responses to cocaine-related stimuli in cocaine abuse patients.
Psychopharmacology 1992;107(4):523-9.
1992: Charles P O'Brien; Arthur I Alterman; Anna Rose Childress; A Thomas McLellan
Developing and evaluating new treatments for alcoholism and cocaine dependence.
Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism 1992;10():303-25.
1992: Scott A Mackler; Charles P O'Brien
Cocaine abuse.
Advances in internal medicine 1992;37():21-35.
1992: Charles P O'Brien; Anna Rose Childress; A Thomas McLellan; Ronald N Ehrman
A learning model of addiction.
Research publications - Association for Research in Nervous and Mental Disease 1992;70():157-77.
1991: David Metzger; George E Woody; D De Philippis; A Thomas McLellan; Charles P O'Brien; Jerome J Platt
Risk factors for needle sharing among methadone-treated patients.
The American journal of psychiatry 1991;148(5):636-40.
1991: Charles P O'Brien; Anna Rose Childress; A Thomas McLellan
Conditioning factors may help to understand and prevent relapse in patients who are recovering from drug dependence.
NIDA research monograph 1991;106():293-312.
1991: Anna Rose Childress; A Thomas McLellan; George E Woody; Charles P O'Brien
Are there minimum conditions necessary for methadone maintenance to reduce intravenous drug use and AIDS risk behaviors?
NIDA research monograph 1991;106():167-77.
1991: George E Woody; A Thomas McLellan; Charles P O'Brien; Lester Luborsky
Addressing psychiatric comorbidity.
NIDA research monograph 1991;106():152-66.
1991: Ronald N Ehrman; Steven J Robbins; Anna Rose Childress; A Thomas McLellan; Charles P O'Brien
Responding to drug-related stimuli in humans as a function of drug-use history.
NIDA research monograph 1991;(116):231-44.
1990: George E Woody; Lester Luborsky; A Thomas McLellan; Charles P O'Brien
Corrections and revised analyses for psychotherapy in methadone maintenance patients.
Archives of general psychiatry 1990;47(8):788-9.
1990: George E Woody; A Thomas McLellan; Charles P O'Brien
Research on psychopathology and addiction: treatment implications.
Drug and alcohol dependence 1990;25(2):121-3.
1990: Charles P O'Brien; Anna Rose Childress; T McLellan; Ronald N Ehrman
Integrating systemic cue exposure with standard treatment in recovering drug dependent patients.
Addictive behaviors 1990;15(4):355-65.
1990: J W Ternes; Charles P O'Brien
The opioids: abuse liability and treatments for dependence.
Advances in alcohol & substance abuse 1990;9(1-2):27-45.
1990: George E Woody; A Thomas McLellan; Charles P O'Brien
Clinical-behavioral observations of the long-term effects of drug abuse.
NIDA research monograph 1990;101():71-85.
1990: George E Woody; David Metzger; B Wu; P Druley; A Thomas McLellan; Charles P O'Brien
Preliminary results of polymerase chain reaction (PCR) testing of ELISA negative IVDUs in methadone treatment.
NIDA research monograph 1990;105():492-3.
1990: D S Metzger; George E Woody; P Druley; D DePhillips; Helen Navaline; A Thomas McLellan; Charles P O'Brien
Psychiatric symptoms, high risk behaviors and HIV positivity among methadone patients.
NIDA research monograph 1990;105():490-1.
1989: George E Woody; Charles P O'Brien; A T McClellan
Drug abuse programs raise QA concerns.
QA review : quality assurance news and views 1989;1(5):2-3.
1989: I Maany; V Dhopesh; I O Arndt; W Burke; George E Woody; Charles P O'Brien
Increase in desipramine serum levels associated with methadone treatment.
The American journal of psychiatry 1989;146(12):1611-3.
1989: Charles P O'Brien; Arthur I Alterman; D Walter; Anna Rose Childress; A Thomas McLellan
Evaluation of treatment for cocaine dependence.
NIDA research monograph 1989;95():78-84.
1989: D S Metzger; J Cornish; George E Woody; A Thomas McLellan; P Druley; Charles P O'Brien
Naltrexone in federal probationers.
NIDA research monograph 1989;95():465-6.
1989: I Arndt; L Dorozynsky; G Woody; A Thomas McLellan; Charles P O'Brien
Desipramine treatment of cocaine abuse in methadone maintenance patients.
NIDA research monograph 1989;95():322-3.
1989: George E Woody; D S Metzger; A Thomas McLellan; Charles P O'Brien; D DiPhilipis
Psychiatric symptoms in HIV test consenters and refusers.
NIDA research monograph 1989;95():415-6.
1988: Charles P O'Brien; L Y Terenius; F Nyberg; A Thomas McLellan; I Eriksson
Endogenous opioids in cerebrospinal fluid of opioid-dependent humans.
Biological psychiatry 1988;24(6):649-62.
1988: Eric W Corty; Charles P O'Brien; S Mann
Reactivity to alcohol stimuli in alcoholics: is there a role for temptation?
Drug and alcohol dependence 1988;21(1):29-36.
1988: Charles P O'Brien; Anna Rose Childress; I O Arndt; A Thomas McLellan; George E Woody; I Maany
Pharmacological and behavioral treatments of cocaine dependence: controlled studies.
The Journal of clinical psychiatry 1988;49 Suppl():17-22.
1987: I Maany; Charles P O'Brien; George E Woody
Interaction between thioridazine and naltrexone.
The American journal of psychiatry 1987;144(7):966.